We have read with great interest the recent article by Martino et al. 1 about lower respiratory tract virus infections as a risk factor for invasive aspergillosis. The established risk factors for aspergillosis in patients after allogeneic hematopoietic SCT (HSCT) include duration of neutropenia, use of steroids, donor type, underlying disease, age, and presence and treatment of GVHD. [2] [3] [4] The authors of this study 1 analyzed the incidence and risk factors for the occurrence of invasive aspergillosis among 219 recipients of allogeneic HSCT after a reduced-intensity conditioning regimen. They showed that steroid therapy for GVHD and the occurrence of a lower respiratory tract infection caused by a respiratory virus were independent risk factors for the development of invasive aspergillosis.
Here we report the case of a 45-year-old woman with a history of extensive chronic GVHD of the lungs (bronchiolitis obliterans), gastrointestinal tract, liver and skin following myeloablative allogeneic HSCT for AML 3 years earlier. She was under triple immunosuppression with prednisolone, tacrolimus and mycophenolate when she developed rhinitis, productive cough and chest pain. Influenza A virus was isolated from a nasopharyngeal swab and treatment with oseltamivir and i.v. Igs was initiated. A computed tomography (CT) of the chest done at this time was normal. However, treatment symptoms persisted and another CT scan was performed 1 week later. The picture was suggestive of pulmonary aspergillosis (Figure 1a) . Treatment with voriconazole was added and the symptoms improved. The follow-up CT 2 weeks later revealed the formation of a massive cavitation (Figure 1b) . Treatment was empirically changed to liposomal amphotericin B and meropenem, and partial resection of the right lower pulmonary lobe was performed. Histological and microbiological investigations showed a polymicrobial infection with the presence of zygomycete Rhizopus microsporus (Figures 2a and b) , Enterococcus faecium and coagulasenegative staphylococci. On treatment with liposomal amphotericin B and antibiotics, the infections resolved.
This case is in line with the paper by Martino et al. 1 and illustrates how influenza virus triggered this rapidly progressive polymicrobial disease in a severely immunocompromised patient with active chronic GVHD late www.nature.com/bmt (3 years) after transplantation. We think it is of great importance to reassess patients clinically and radiologically by CT scan when respiratory symptoms persist despite appropriate treatment. Polymicrobial disease is not rare in heavily immunocompromised patients.
